[Drug treatment of Alzheimer's dementia : Status quo and perspectives]. / Pharmakologische Therapie der Alzheimer-Demenz : Aktueller Stand und Perspektiven.
Internist (Berl)
; 60(7): 761-768, 2019 Jul.
Article
em De
| MEDLINE
| ID: mdl-31139854
ABSTRACT
Alzheimer's disease (AD) is a neurodegenerative disease of the central nervous system. AD is characterized by progressive impairments of memory as well as other cognitive functions and an increasing loss of autonomy in everyday life. This review article provides an overview of the current state-of-the-art (symptomatic) pharmacological treatment of Alzheimer's disease, specifics in the context of concomitant neuropsychiatric symptoms in multimorbid patients, and drugs currently under development that have a potentially causal (disease modifying) effect are also mentioned.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Memantina
/
Inibidores da Colinesterase
/
Doença de Alzheimer
Limite:
Humans
Idioma:
De
Revista:
Internist (Berl)
Ano de publicação:
2019
Tipo de documento:
Article